Evidence map›Paper›PMID 38320788›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2024

[A cross-sectional survey on the types of antiviral treatment plans for patients with chronic hepatitis B].

X L Xue, Q G Mao, Q F Ruan, F Min, W Q Huang, X T Zheng, H Q Liang

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

X L XueThe First Affiliated Hospital of Xiamen University, Xiamen 361003, China.
Q G MaoXiamen Hospital of T.C,M., Xiamen 361015, China.
Q F RuanXiamen Hospital of T.C,M., Xiamen 361015, China.
F MinArmy 73rd Group Military Hospital, Xiamen 361003, China.
W Q HuangXiamen Humanity Hospital, Xiamen 361016, China.
X T ZhengXiamen Hospital of T.C,M., Xiamen 361015, China.
H Q LiangXiamen Hospital of T.C,M., Xiamen 361015, China.
First Affiliated Hospital of Xiamen University · CN

Funding

National Natural Science Foundation of China 82174141, 82374353Natural Science Foundation of Fujian Province 2023J011636Support Project for Young Qihuang Scholars of State Administration of Traditional Chinese Medicine 200 (2021),256 (2022)Xiamen Medical and Health Guidance Project 3502Z20224ZD1166Xiamen Science and Technology Planning Project 3502Z20224018Xiamen Traditional Chinese Medicine Support Project XWZY-2023-0202
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis B, ChronicAntiviral AgentsCross-Sectional StudiesHepatitis B e AntigensHepatitis B Surface AntigensHepatitis B virusHumansInterferon-alphaPolyethylene GlycolsTreatment OutcomeAntiviral AgentsHepatitis B e AntigensHepatitis B Surface AntigensInterferon-alphaPolyethylene GlycolsAntiviral therapyChronic hepatitis BCross-sectional survey

Identifiers

PMID38320788
PMCPMC12814160
OpenAlexW4394767190

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.